Who has invested in Conexa Saude?

Goldman Sachs, General Atlantic, Vivo, Pá��ia, GA, b.bricks are named among the investors backing Conexa Saude.

Conexa Saude Funding: $585M Raised, Series C (2022)

Conexa Saude funding overview

Conexa Saude is based in Rio de Janeiro, Brazil. Conexa Saude has raised $585M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2022. The round record for Conexa Saude runs through 2022; nothing later has been disclosed. Investors on record include Goldman Sachs, General Atlantic, Vivo, Pá��ia, GA, b.bricks and 2 others. 8 distinct backers are named across the disclosed rounds.

Conexa Saude at a glance

Total raised: $585M
Latest round: Series C
Latest round date: June 2022
Headquarters: Rio de Janeiro, Brazil
Notable investors: Goldman Sachs, General Atlantic, Vivo, Pá��ia, GA, b.bricks, Luiz Fraga, Guilherme Fraga

Frequently asked about Conexa Saude funding

How much has Conexa Saude raised?: Conexa Saude has raised $585M in total disclosed funding across the rounds on record.
Who has invested in Conexa Saude?: Goldman Sachs, General Atlantic, Vivo, Pá��ia, GA, b.bricks are named among the investors backing Conexa Saude.
What was the latest Conexa Saude funding round?: The most recent disclosed round is a Series C, announced in June 2022.
Where is Conexa Saude based?: Conexa Saude is based in Rio de Janeiro, Brazil.
When did Conexa Saude last raise?: The last disclosed Conexa Saude round closed in June 2022 at Series C.

Conexa Saude totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Rio de Janeiro below to benchmark round size and investor mix.

Conexa Saude Funding: $585M Raised, Series C (2022)

Conexa Saude funding overview

Conexa Saude at a glance

Frequently asked about Conexa Saude funding

Companies related to Conexa Saude (27)

Browse related funding lists (5)